维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="Reck P"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Phase III trial of cispl-atin plus gemcitabine with either placebo or bevacizumab asfirst-line therapy for nonsquamous non-small-cell lung cancer:Avail显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
2	Final safety results of BO17704(A-VAiL):a phase III randomized study of first-line bevacizumab(BV)and cisplatin/gemcitabine(CG)in patients(pts)with ad-vanced or recurrent nonsquamous non-small cell lung cancer(NSCLC)显示文摘	Hirsh V Ramlau R von Pawel J Zatloukal P Vera G Leighl N Mezger J Archer V Reck M	2009	J Clin Oncol2009，，：	1
3	Diagnostic sensitivity and apecificity Of Doppler ultrasound in rheumatoid arthritis 显示文摘	Tendev L yon der Recke P Torp-Pedersen S	2008	J Rheumatol2008，35，1：	1
4	PhaseⅢtrial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-smallcell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
5	Overall survival with cispl- atin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAIL)显示文摘	Reck M yon Pawel J Zatloukal P	2010	Ann Oncol2010，21，9：	1
6	PhaseⅢ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P		0，，：	1
7	Phase El trial of cispl-atin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
8	A model for predicting transition in railgun fiber brush armatures显示文摘	Reck B Lehmann P Spahn E	2009	IEEE Transactions on Magnetics2009，45，1：	1
9	Phase III trial of eisplatin plus gemcitabine with either placebo or bevaeizumab as firstline therapy for nonsquamous non-small-cell lung cancer: AVAil 显示文摘	Reck M yon Pawel J Zatloukl P	2009	J ClinOncol2009，27，8：	1
10	Phase Ⅲ trial of cisplatine plus gemcitabine with either placebo or bevaci- zumab as first-line therapy for nonsquamons non-small- cell lung cancer显示文摘	Reck M von Rawel J Zatlonkal P	2009	AVAil J Clin Onc2009，27，8：	1
11	Diagnostic sensitivity and specificity of Doppler ultrasound in rheumatoid arthritis显示文摘	Terslev L vun der Recke P Torp-Pedersen S	2008	J Rheumatol2008，35，：	1
12	Diagnostic sensitivity and specificity of Doppler ultrasound in rheumatoid arthritis显示文摘	Terslev L von der Recke P Torp-Pedersen S		0，，01：	1
13	Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
14	Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer:results from a randomized phase Ⅲ trial (AVAiL)显示文摘	Reck M von Pawel J Zatloukal P		0，，09：	1
15	Phase III trial of cisplatin plus gemeitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAIL 显示文摘	Reck M Von-Pawel J Zatloukal P	2009	J Clin Oncol2009，27，：	1
16	Estimation of the effect of salmon calcitonin in established osteo- porosis by biochemical bone markers 显示文摘	NIELSEN N M VON DER RECKE P HANSEN M A	1994	Calcif Tissue Int1994，55，1：	1
17	Phase Ⅲ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for non-small cell lung cancer :AVAiL 显示文摘	Reck M van Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
18	Overall survival with cispl-atin-gemcitabine and bevacizumab or placebo as first-line therapy fornonsquamous non-small-cell lung cancer: results from a randomisedphase III trial (AVAiL)显示文摘	Reck M von Pawel J Zatloukal P	2010	Ann Oncol2010，21，9：	1
19	Phase Ⅲ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer:AVAil显示文摘	Reck M von PJ Zatloukal P		0，，8：	1
20	Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small cell lung cancer: from a randomized phase Ⅲ trail (AVAiL) 显示文摘	Reck M yon Pawel J Zatloukal P	2010	Ann Oncol2010，21，9：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示